reboxetine has been researched along with quipazine in 1 studies
| Studies (reboxetine) | Trials (reboxetine) | Recent Studies (post-2010) (reboxetine) | Studies (quipazine) | Trials (quipazine) | Recent Studies (post-2010) (quipazine) |
|---|---|---|---|---|---|
| 626 | 193 | 184 | 658 | 0 | 41 |
| Protein | Taxonomy | reboxetine (IC50) | quipazine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 3E | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 3B | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 1.4454 | |
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 0.47 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 1.4 | |
| 5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 2.7 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.0617 | |
| 5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 3.7297 | |
| 5-hydroxytryptamine receptor 3A | Rattus norvegicus (Norway rat) | 0.0035 | |
| 5-hydroxytryptamine receptor 3A | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 1D | Sus scrofa (pig) | 3.7153 | |
| Adenylate cyclase type 5 | Rattus norvegicus (Norway rat) | 1.4454 | |
| 5-hydroxytryptamine receptor 3D | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 2A | Bos taurus (cattle) | 3.4674 | |
| 5-hydroxytryptamine receptor 3C | Homo sapiens (human) | 0.0004 | |
| 5-hydroxytryptamine receptor 3B | Rattus norvegicus (Norway rat) | 0.0035 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aryal, DK; Deng, JV; Hutchinson, AN; West, AE; Wetsel, WC | 1 |
1 other study(ies) available for reboxetine and quipazine
| Article | Year |
|---|---|
Differential regulation of MeCP2 phosphorylation in the CNS by dopamine and serotonin.
Topics: Animals; Brain; Cells, Cultured; Citalopram; Colforsin; Dopamine; Dopamine Agonists; Drug Interactions; GABAergic Neurons; Gene Expression Regulation; Male; Methyl-CpG-Binding Protein 2; Mice; Mice, Knockout; Microinjections; Molecular Imaging; Morpholines; Motor Activity; Phosphorylation; Piperazines; Plasma Membrane Neurotransmitter Transport Proteins; Quipazine; Reboxetine; Serotonin | 2012 |